An update on the treatment of premature ejaculation: A systematic review

References

• Saitz TR, Serefoglu EC. The epidemiology of premature ejaculation. Transl Androl Urol. 2016;5(4):409–415.
   PubMed Web of Science ®Google Scholar
• Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sex Med. 2014;2(2):41–59.
   PubMed Web of Science ®Google Scholar
• El-Hamd MA, Saleh R, Majzoub A. Premature ejaculation: an update on definition and pathophysiology. Asian J Androl. 2019;21(5):425–432.
   PubMed Web of Science ®Google Scholar
• Majzoub A, Arafa M, Al-Said S, et al. Premature ejaculation in type II diabetes mellitus patients: association with glycemic control. Transl Androl Urol. 2016;5(2):248–254.
   Web of Science ®Google Scholar
• Althof SE, McMahon CG, Waldinger MD, et al. An Update of the International Society of Sexual Medicine’s Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE). Sex Med. 2014 Jun;2(2):60–90.
   PubMed Web of Science ®Google Scholar
• Althof SE, Abdo CH, Dean J, et al. International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med. 2010;7(9):2947–2969.
   PubMed Web of Science ®Google Scholar
• Wang WF, Chang L, Minhas S, et al. Selective serotonin reuptake inhibitors in the treatment of premature ejaculation. Chin Med J (Engl). 2007;120(11):1000–1006.
   Web of Science ®Google Scholar
• Hellstrom WJ. Available and future therapies for premature ejaculation. Drugs Today (Barc). 2010;46(7):507–521.
   Web of Science ®Google Scholar
• Hellstrom WJ. Update on treatments for premature ejaculation. Int J Clin Pract. 2011;65(1):16–26.
   Web of Science ®Google Scholar
• Richardson D, Goldmeier D. Pharmacological treatment for premature ejaculation. Int J STD AIDS. 2005;16(10):709–711.
   PubMed Web of Science ®Google Scholar
• Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am Fam Physician. 2003;68(3):498–504.
   Web of Science ®Google Scholar
• Semans JH. Premature ejaculation: a new approach. South Med J. 1956;49(4):353–358.
   PubMedGoogle Scholar
• Masters WM, Johnson VE. Human sexual inadequacy. Boston, MA: Little, Brown; 1970.
   Google Scholar
• de Carufel F, Trudel G. Effects of a new functional-sexological treatment for premature ejaculation. J Sex Marital Ther. 2006;32(2):97–114.
   PubMed Web of Science ®Google Scholar
• Althof SE, Wieder M. Psychotherapy for erectile dysfunction: now more relevant than ever. Endocrine. 2004;23(2–3):131–134.
   Web of Science ®Google Scholar
• Althof S. The psychology of premature ejaculation: therapies and consequences. J Sex Med. 2006;3(Suppl 4):324–331.
   PubMedGoogle Scholar
• Althof S. Therapeutic weaving: the integration of treatment techniques. In: Levine S, Risen C, Althof S, editors. Handbook of Clinical Sexuality for Mental Health Professionals. New York, NY: Bruner-Routledge; 2003. pp. 359–376
   Google Scholar
• Hawton K, Catalan J, Martin P, et al. Long-term outcome of sex therapy. Behav Res Ther. 1986;24(6):665–675.
   PubMed Web of Science ®Google Scholar
• De Amicis LA, Goldberg DC, LoPiccolo J, et al. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav. 1985;14(6):467–489.
   Web of Science ®Google Scholar
• Sharlip I. Diagnosis and treatment of premature ejaculation: the physician’s perspective. J Sex Med. 2005;2(Suppl 2):103–109.
   Google Scholar
• Labrid C, Moleyre J, Poignant JC, et al. Structure-activity relationships of tricyclic antidepressants, with special reference to tianeptine. Clin Neuropharmacol. 1988;11(Suppl 2):S21–31.
   Google Scholar
• Goodman WK, Gilman HM. The pharmacological basis of therapeutics. 8th ed. New York, NY: Pergamon Press; 1990.
   Google Scholar
• Koen N, Stein DJ. Pharmacotherapy of anxiety disorders: a critical review. Dialogues Clin Neurosci. 2011;13(4):423–437.
   PubMedGoogle Scholar
• Segraves RT, Saran A, Segraves K, et al. Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther. 1993;19(3):198–200.
   PubMed Web of Science ®Google Scholar
• Colpi GM, Fanciullacci F, Aydos K, et al. Effectiveness mechanism of chlomipramine by neurophysiological tests in subjects with true premature ejaculation. Andrologia. 1991;23(1):45–47.
   Web of Science ®Google Scholar
• Strassberg DS, de Gouveia Brazao CA, Rowland DL, et al. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther. 1999;25(2):89–101.
   PubMed Web of Science ®Google Scholar
• Waldinger MD, Zwinderman AH, Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol. 2004;46(4):510–516.
   Web of Science ®Google Scholar
• Kim SW, Choi JB, Kim SJ, et al. Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose, parallel-grouped clinical study. Int J Impot Res. 2018;30(2):65–70.
   PubMed Web of Science ®Google Scholar
• Balon R. Antidepressants in the treatment of premature ejaculation. J Sex Marital Ther. 1996;22(2):85–96.
   PubMed Web of Science ®Google Scholar
• Patterson WM. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1993;54(2):71.
   PubMed Web of Science ®Google Scholar
• McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol. 1998;159(6):1935–1938.
   Web of Science ®Google Scholar
• Owens MJ, Knight DL, Nemeroff CB. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry. 2001;50(5):345–350.
   PubMed Web of Science ®Google Scholar
• Waldinger MD, Olivier B. Utility of selective serotonin reuptake inhibitors in premature ejaculation. Curr Opin Invest Drugs. 2004;5(7):743–747.
   PubMedGoogle Scholar
• Olivier B, Chan JS, Pattij T, et al. Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions? Int J Impot Res. 2006;18(Suppl 1):S14–23.
   Google Scholar
• Siesser WB, Sachs BD, Ramsey AJ, et al. Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice. ACS Chem Neurosci. 2013;4(1):84–88.
   PubMed Web of Science ®Google Scholar
• Albert PR, Lemonde S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist. 2004;10(6):575–593.
   PubMed Web of Science ®Google Scholar
• Waldinger MD, Schweitzer DH, On-demand OB. SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med. 2005;2(1):121–131.
   PubMed Web of Science ®Google Scholar
• Altieri SC, Garcia-Garcia AL, Leonardo ED, et al. Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior. ACS Chem Neurosci. 2013;4(1):72–83.
   Web of Science ®Google Scholar
• Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001;62(Suppl 3):10–21.
   PubMed Web of Science ®Google Scholar
• Black K, Shea C, Dursun S, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci. 2000;25(3):255–261.
   PubMed Web of Science ®Google Scholar
• Greenier E, Lukyanova V, Reede L. Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions. AANA J. 2014;82(5):340–345.
   Google Scholar
• Goodnick PJ. Pharmacokinetics of second generation antidepressants: fluoxetine. Psychopharmacol Bull. 1991;27(4):503–512.
   Google Scholar
• Marksteiner J, Walch T, Bodner T, et al. Fluoxetine in Alzheimer’s disease with severe obsessive compulsive symptoms and a low density of serotonin transporter sites. Pharmacopsychiatry. 2003;36(5):207–209.
   Web of Science ®Google Scholar
• Sommi RW, Crismon ML, Bowden CL. Fluoxetine: a serotonin-specific, second-generation antidepressant. Pharmacotherapy. 1987;7(1):1–15.
   PubMed Web of Science ®Google Scholar
• Hsieh JT, Chang HC, Law HS, et al. In vivo evaluation of serotonergic agents and alpha-adrenergic blockers on premature ejaculation by inhibiting the seminal vesicle pressure response to electrical nerve stimulation. Br J Urol. 1998;82(2):237–240.
   Google Scholar
• Kara H, Aydin S, Yucel M, et al. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol. 1996;156(5):1631–1632.
   Web of Science ®Google Scholar
• Jenkins LC, Gonzalez J, Tal R, et al. Compliance with fluoxetine use in men with primary premature ejaculation. J Sex Med. 2019;16(12):1895–1899.
   Web of Science ®Google Scholar
• Yilmaz U, Tatlisen A, Turan H, et al. The effects of fluoxetine on several neurophysiological variables in patients with premature ejaculation. J Urol. 1999;161(1):107–111.
   Web of Science ®Google Scholar
• Manasia P, Pomerol J, Ribe N, et al. Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation. J Urol. 2003;170(1):164–165.
   Web of Science ®Google Scholar
• Hosseini MM, Yarmohammadi H. Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation. Urol Int. 2007;79(1):28–32.
   Web of Science ®Google Scholar
• Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. Urol Int. 2008;80(2):162–165.
   PubMed Web of Science ®Google Scholar
• Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun. 1994;62(6):2536–2544.
   Web of Science ®Google Scholar
• Pollock BG. Citalopram: a comprehensive review. Expert Opin Pharmacother. 2001;2(4):681–698.
   PubMedGoogle Scholar
• Atmaca M, Kuloglu M, Tezcan E, et al. The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res. 2002;14(6):502–505.
   Web of Science ®Google Scholar
• Safarinejad MR, Hosseini SY. Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study. Int J Impot Res. 2006;18(2):164–169.
   Web of Science ®Google Scholar
• Akgul T, Karakan T, Ayyildiz A, et al. Comparison of sertraline and citalopram for treatment of premature ejaculation. Urol J. 2008;5(1):41–45.
   Google Scholar
• Madeo B, Bettica P, Milleri S, et al. The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. J Sex Med. 2008;5(10):2431–2441.
   PubMed Web of Science ®Google Scholar
• Dadfar MR, Baghinia MR. Salvage use of citalopram for treatment of fluoxetine-resistant premature ejaculation in recently married men: a prospective clinical trial. J Urol. 2010;7(1):40–44.
   Web of Science ®Google Scholar
• Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry. 2002;63(4):331–336.
   PubMed Web of Science ®Google Scholar
• Wade A, Michael Lemming O, Bang Hedegaard K. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol. 2002;17(3):95–102.
   Web of Science ®Google Scholar
• Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr. 2002;7(Suppl 1):40–44.
   PubMed Web of Science ®Google Scholar
• Owens MJ, Rosenbaum JF. Escitalopram: a second-generation SSRI. CNS Spectr. 2002;7(Suppl 1):34–39.
   PubMed Web of Science ®Google Scholar
• Sanchez C, Brennum L. The S-enantiomer of citalopram (Lu 26-054) is a highly selective and potent serotonin reuptake inhibitor. Biol Psychiatry. 2000;47:885.
   Web of Science ®Google Scholar
• Rosenthal MH, Li D Efficacy and tolerability of escitalopram in patients intolerant of other SSRIs. 23rd Congress of the Collegium internationale Neuro-Psychopharmacologium; Montreal, Canada 2002.
   Google Scholar
• Safarinejad MR. Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol. 2007;27(5):444–450.
   Web of Science ®Google Scholar
• Saleh R, Nada E, Abu Al HM. The use of escitalopram in treatment of patients with premature ejaculation: a randomized, double-blind, placebo-controlled study. 2008;22(1):48–56. Egyptian Journal of Andrology and Reproduction.
   Google Scholar
• Arafa M, Shamloul R. A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaire. Ther Clin Risk Manag. 2007;3(4):527–531.
   Google Scholar
• Cipriani A, La Ferla T, Furukawa TA, et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2010;14(4):CD006117.
   Google Scholar
• Koe BK. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. J Clin Psychiatry. 1990;51(Suppl B):13–17.
   Google Scholar
• Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology. 1999;54(3):544–547.
   PubMed Web of Science ®Google Scholar
• Arafa M, Shamloul R. Efficacy of sertraline hydrochloride in treatment of premature ejaculation: a placebo-controlled study using a validated questionnaire. Int J Impot Res. 2006;18(6):534–538.
   Web of Science ®Google Scholar
• Xu G, Jiang HW, Fang J, et al. An improved dosage regimen of sertraline hydrochloride in the treatment for premature ejaculation: an 8-week, single-blind, randomized controlled study followed by a 4-week, open-label extension study. J Clin Pharm Ther. 2014;39(1):84–90.
   Web of Science ®Google Scholar
• Heydorn WE. Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders. Expert Opin Investig Drugs. 1999;8(4):417–441.
   PubMedGoogle Scholar
• Green B. Focus on paroxetine. Curr Med Res Opin. 2003;19(1):13–21.
   PubMed Web of Science ®Google Scholar
• Waldinger MD, Hengeveld MW, Zwinderman AH. Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol. 1997;79(4):592–595.
   Google Scholar
• McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res. 1999;11(5):241–246.
   Web of Science ®Google Scholar
• Safarinejad MR. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Clin Neuropharmacol. 2006;29(5):243–252.
   Web of Science ®Google Scholar
• Alghobary M, El-Bayoumy Y, Mostafa Y, et al. Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation. J Sex Med. 2010;7(8):2860–2867.
   Web of Science ®Google Scholar
• Kaplan HI, Sadock BJ. Psychiatric drug treatment. Baltimore: Williams and Wilkins Press; 1996.
   Google Scholar
• Waldinger MD, Hengeveld MW, Zwinderman AH, et al. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol. 1998;18(4):274–281.
   PubMed Web of Science ®Google Scholar
• Dresser MJ, Desai D, Gidwani S, et al. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int J Impot Res. 2006;18(1):104–110.
   Web of Science ®Google Scholar
• Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for ‘on-demand’ treatment of premature ejaculation. BJU Int. 2006;97(2):311–315.
   PubMed Web of Science ®Google Scholar
• Buvat J, Tesfaye F, Rothman M, et al. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol. 2009;55(4):957–967.
   PubMed Web of Science ®Google Scholar
• Kaufman JM, Rosen RC, Mudumbi RV, et al. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. BJU Int. 2009;103(5):651–658.
   PubMed Web of Science ®Google Scholar
• McMahon C, Kim SW, Park NC, et al. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med. 2010;7(1 Pt 1):256–268.
   PubMed Web of Science ®Google Scholar
• Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet. 2006;368(9539):929–937.
   PubMed Web of Science ®Google Scholar
• McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012;4(5):233–251.
   PubMedGoogle Scholar
• Abu El-Hamd M, Abdelhamed A. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial. Andrologia. 2018;50:1.
   Web of Science ®Google Scholar
• Simsek A, Kirecci SL, Kucuktopcu O, et al. Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation. Asian J Androl. 2014;16(5):725–727.
   Web of Science ®Google Scholar
• Roy K, Roy PP. QSAR of cytochrome inhibitors. Expert Opin Drug Metab Toxicol. 2009;5(10):1245–1266.
   PubMed Web of Science ®Google Scholar
• Spina E, Santoro V, D’Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008;30(7):1206–1227.
   PubMed Web of Science ®Google Scholar
• Vandel S, Bertschy G, Baumann P, et al. Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients. Pharmacol Res. 1995;31(6):347–353.
   PubMed Web of Science ®Google Scholar
• Muller N, Brockmoller J, Roots I. Extremely long plasma half-life of amitriptyline in a woman with the cytochrome P450IID6 29/29-kilobase wild-type allele--a slowly reversible interaction with fluoxetine. Ther Drug Monit. 1991;13(6):533–536.
   Web of Science ®Google Scholar
• Joos AA, Konig F, Frank UG, et al. Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer. Pharmacopsychiatry. 1997;30(6):266–270.
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K, Obach RS. In vitro-in vivo extrapolation of CYP2D6 inactivation by paroxetine: prediction of nonstationary pharmacokinetics and drug interaction magnitude. Drug Metab Dispos. 2005;33(6):845–852.
   PubMed Web of Science ®Google Scholar
• Fritze J, Unsorg B, Lanczik M. Interaction between carbamazepine and fluvoxamine. Acta Psychiatr Scand. 1991;84(6):583–584.
   Web of Science ®Google Scholar
• Kasper S, Resinger E. Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors. Eur Neuropsychopharmacol. 2001;11(4):307–321.
   PubMed Web of Science ®Google Scholar
• Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. 2013;13(4):533–540.
   PubMedGoogle Scholar
• Hemeryck A, Belpaire FM. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab. 2002;3(1):13–37.
   PubMed Web of Science ®Google Scholar
• Atikeler MK, Gecit I, Senol FA. Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia. 2002;34(6):356–359.
   PubMed Web of Science ®Google Scholar
• Sahin H, Bircan MK. Re: efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol. 1996;156(5):1783–1784.
   Web of Science ®Google Scholar
• Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int. 2004;93(7):1018–1021.
   PubMed Web of Science ®Google Scholar
• Jannini EA, Simonelli C, Lenzi A. Disorders of ejaculation. J Endocrinol Invest. 2002;25(11):1006–1019.
   Web of Science ®Google Scholar
• Atan A, Basar MM, Aydoganli L. Comparison of the efficacy of fluoxetine alone vs. fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation. Arch Esp Urol. 2000;53(9):856–858.
   Google Scholar
• Choi HK, Jung GW, Moon KH, et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology. 2000;55(2):257–261.
   PubMed Web of Science ®Google Scholar
• Choi HK, Xin ZC, Choi YD, et al. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Impot Res. 1999;11(5):261–264.
   PubMed Web of Science ®Google Scholar
• Xin ZC, Choi YD, Lee WH, et al. Penile vibratory threshold changes with various doses of SS-cream in patients with primary premature ejaculation. Yonsei Med J. 2000;41(1):29–33.
   PubMed Web of Science ®Google Scholar
• Dinsmore WW, Wyllie MG. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int. 2009;103(7):940–949.
   PubMed Web of Science ®Google Scholar
• Dinsmore WW, Hackett G, Goldmeier D, et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int. 2007;99(2):369–375.
   PubMed Web of Science ®Google Scholar
• Gurkan L, Oommen M, Hellstrom WJ. Premature ejaculation: current and future treatments. Asian J Androl. 2008;10(1):102–109.
   Web of Science ®Google Scholar
• Abdel-Hamid IA. Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action. Drugs. 2004;64(1):13–26.
   Web of Science ®Google Scholar
• Li X, Zhang SX, Cheng HM, et al. [Clinical study of sildenafil in the treatment of premature ejaculation complicated by erectile dysfunction]. Zhonghua Nan Ke Xue. 2003;9(4):266–269.
   Google Scholar
• McMahon CG, Stuckey BG, Andersen M, et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med. 2005;2(3):368–375.
   PubMed Web of Science ®Google Scholar
• Tang W, Ma L, Zhao L, et al. Clinical efficacy of Viagra with behavior therapy against premature ejaculation. Zhonghua Nan Ke Xue. 2004;10(5):366–267, 370.
   PubMedGoogle Scholar
• Salonia A, Maga T, Colombo R, et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol. 2002;168(6):2486–2489.
   PubMed Web of Science ®Google Scholar
• Chen J, Mabjeesh NJ, Matzkin H, et al. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology. 2003;61(1):197–200.
   PubMed Web of Science ®Google Scholar
• Zhang XS, Wang YX, Huang XY, et al. Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation. Zhonghua Nan Ke Xue. 2005;11(7):520–522, 525.
   Google Scholar
• Wang WF, Wang Y, Minhas S, et al. Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol. 2007;14(4):331–335.
   Web of Science ®Google Scholar
• Aversa A, Pili M, Francomano D, et al. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res. 2009;21(4):221–227.
   Web of Science ®Google Scholar
• Dell’Atti L, Galosi AB, Ippolito C. A randomized single-center study to compare the efficacy and tolerability of tadalafil once daily plus lidocaine anesthetic spray on premature ejaculation. Eur Rev Med Pharmacol Sci. 2017;21(5):1036–1040.
   PubMed Web of Science ®Google Scholar
• Salem EA, Wilson SK, Bissada NK, et al. Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med. 2008;5(1):188–193.
   PubMed Web of Science ®Google Scholar
• Xiong GG, Wu FH, Chen SH, et al. [Safety and efficacy of tramadol hydrochloride with behavioral modification in the treatment of premature ejaculation]. Zhonghua Nan Ke Xue. 2011;17(6):538–541.
   Google Scholar
• Bar-Or D, Salottolo KM, Orlando A, et al. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol. 2012;61(4):736–743.
   PubMed Web of Science ®Google Scholar
• Palmer NR. Tramadol for premature ejaculation. J Sex Med. 2009;6(1):299.
   Web of Science ®Google Scholar
• Kim JJ, Kwak TI, Jeon BG, et al. Effects of glans penis augmentation using hyaluronic acid gel for premature ejaculation. Int J Impot Res. 2004;16(6):547–551.
   PubMed Web of Science ®Google Scholar
• Kwak C, Ku JH, Kim T, et al. Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology. 2003;62(5):854–859.
   Web of Science ®Google Scholar
• Moon DG. Is there a place for surgical treatment of premature ejaculation? Transl Androl Urol. 2016;5(4):502–507.
   Web of Science ®Google Scholar
• Basal S, Goktas S, Ergin A, et al. A novel treatment modality in patients with premature ejaculation resistant to conventional methods: the neuromodulation of dorsal penile nerves by pulsed radiofrequency. J Androl. 2010;31(2):126–130.
   PubMedGoogle Scholar
• Gallo L, Perdona S, Gallo A. The role of short frenulum and the effects of frenulectomy on premature ejaculation. J Sex Med. 2010;7(3):1269–1276.
   Web of Science ®Google Scholar
• Song B, Cai ZM. Possible function of the frenulum of prepuce in penile erection. Andrologia. 2012;44(1):23–25.
   Web of Science ®Google Scholar
• Namavar MR, Robati B. Removal of foreskin remnants in circumcised adults for treatment of premature ejaculation. Urol Ann. 2011;3(2):87–92.
   Google Scholar
• Comhaire F, Vermeulen A. Plasma testosterone in patients with varicocele and sexual inadequacy. J Clin Endocrinol Metab. 1975;40(5):824–829.
   Web of Science ®Google Scholar
• Lotti F, Corona G, Mancini M, et al. The association between varicocele, premature ejaculation and prostatitis symptoms: possible mechanisms. J Sex Med. 2009;6(10):2878–2887.
   Web of Science ®Google Scholar
• Ahmed AF, Abdel-Aziz AS, Maarouf AM, et al. Impact of varicocelectomy on premature ejaculation in varicocele patients. Andrologia. 2015;47(3):276–281.
   Web of Science ®Google Scholar
• Asadpour AA, Aslezare M, Nazari Adkani L. et al. The effects of varicocelectomy on the patients with premature ejaculation. Nephrourol Mon. 2014;6(3):e15991.
   Google Scholar
• Abu El‑Hamd M, Abdel Hameed FA. The Role of Varicocelectomy on Patients with Premature Ejaculation and Varicoceles. 2016;3(4):121–125. Journal of Integrative Nephrology and Andrology.
   Google Scholar
• Cavallini G. Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. Eur Urol. 1995;28(2):126–130.
   Web of Science ®Google Scholar
• Sato Y, Otani T, Amano T, et al. Silodosin versus naftopidil in the treatment of premature ejaculation: a prospective multicenter trial. Int J Urol. 2017;24(8):626–631.
   PubMed Web of Science ®Google Scholar
• Başar MM, Yilmaz E, Ferhat M, et al. Terazosin in the treatment of premature ejaculation: a short-term follow-up. Int Urol Nephrol. 2005;37(4):773–777.
   Google Scholar
• Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003;26(3):137–146.
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Carney S, Geddes J, et al. Folate for depressive disorders. Cochrane Database Syst Re. 2003(2):CD003390
   Web of Science ®Google Scholar
• Brocardo PS, Budni J, Kaster MP, et al. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology. 2008;54(2):464–473.
   Web of Science ®Google Scholar
• Botez MI, Young SN, Bachevalier J, et al. Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature. 1979;278(5700):182–183.
   PubMed Web of Science ®Google Scholar
• Botez MI, Young SN, Bachevalier J, et al. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Ann Neurol. 1982;12(5):479–484.
   Web of Science ®Google Scholar
• Saadat SH, Ahmadi K, Panahi Y. The effect of on-demand caffeine consumption on treating patients with premature ejaculation: a double-blind randomized clinical trial. Curr Pharm Biotechnol. 2015;16(3):281–287.
   Web of Science ®Google Scholar
• Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci. 2004;61(7–8):857–872.
   PubMed Web of Science ®Google Scholar
• Serefoglu EC, Hawley WR, Lasker GF, et al. Effect of botulinum-A toxin injection into bulbospongiosus muscle on ejaculation latency in male rats. J Sex Med. 2014;11(7):1657–1663.
   Web of Science ®Google Scholar
• Serefoglu EC, Silay MS. Botulinum toxin-A injection may be beneficial in the treatment of life-long premature ejaculation. Med Hypotheses. 2010;74(1):83–84.
   PubMed Web of Science ®Google Scholar
• Choi JB, Kang SH, Lee DH, et al. Efficacy and safety of on demand clomipramine for the treatment of premature ejaculation: a multicenter, randomized, double-blind, phase III clinical trial. J Urol. 2019;201(1):147–152.
   PubMed Web of Science ®Google Scholar
• Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res. 2001;13(1):41–45.
   PubMed Web of Science ®Google Scholar
• Siroosbakht S, Rezakhaniha S, Rezakhaniha B. Which of available selective serotonin reuptake inhibitors (SSRIs) is more effective in treatment of premature ejaculation? A randomized clinical trial. Int Braz J Urol. 2019;45(6):1209–1215.
   Web of Science ®Google Scholar
• Kim SC, Seo KK. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol. 1998;159(2):425–427.
   Web of Science ®Google Scholar
• Mathers MJ, Klotz T, Roth S, et al. Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study. Andrologia. 2009;41(3):169–175.
   Web of Science ®Google Scholar
• Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharmacol. 1995;15(5):341–346.
   Web of Science ®Google Scholar
• Murat Başar M, Atan A, Yildiz M, et al. Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Arch Esp Urol. 1999;52(9):1008–1011.
   Google Scholar
• Balbay MD, Yildiz M, Salvarci A, et al. Treatment of premature ejaculation with sertralin. Int Urol Nephrol. 1998;30(1):81–83.
   Google Scholar
• Polat EC, Ozbek E, Otunctemur A, et al. Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculation. Andrologia. 2015;47(5):487–492.
   PubMed Web of Science ®Google Scholar
• McMahon CG, Giuliano F, Dean J, et al. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. J Sex Med. 2013;10(9):2312–2325.
   PubMed Web of Science ®Google Scholar
• Tuken M, Culha MG, Serefoglu EC. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study. Int J Impot Res. 2019;31(2):92–96.
   PubMed Web of Science ®Google Scholar
• Peng J, Fang D, Li H, et al. Efficacy of dapoxetine treatment in Chinese patients with premature ejaculation and possible factors affecting efficacy in the real-world practice. BMC Urol. 2020;20(1):11.
   Web of Science ®Google Scholar
• Altamura AC, Moro AR, Percudani M. Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet. 1994;26(3):201–214.
   PubMed Web of Science ®Google Scholar
• Mandrioli R, Forti GC, Raggi MA. Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450. Curr Drug Metab. 2006;7(2):127–133.
   PubMed Web of Science ®Google Scholar
• Bejerot S, Bodlund O. Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder. Acta Psychiatr Scand. 1998;98(5):423–424.
   Web of Science ®Google Scholar
• Baldessarini RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry. 1989;50(4):117–126.
   Web of Science ®Google Scholar
• Sanchez C, Bergqvist PB, Brennum LT, et al. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacol (Berl). 2003;167(4):353–362.
   PubMed Web of Science ®Google Scholar
• Hyttel J, Bogeso KP, Perregaard J, et al. The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer. J Neural Transm Gen Sect. 1992;88(2):157–160.
   PubMed Web of Science ®Google Scholar
• Jiang K, Li L, Wang X, et al. Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population. Neuropsychiatr Dis Treat. 2017;13:515–526.
   Web of Science ®Google Scholar
• Aronson S, Delgado P. Escitalopram. Drugs Today (Barc). 2004;40(2):121–131.
   Web of Science ®Google Scholar
• van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet. 1993;24(3):203–220.
   PubMed Web of Science ®Google Scholar
• De Jonghe F, Swinkels J, Tuyaman Qua H. Randomized double-blind study of fluoxamine and maprotiline in treatment of depression. Pharmacopsychiatry. 1991;24:21–23.
   Web of Science ®Google Scholar
• McMahon CG. Efficacy of dapoxetine in the treatment of premature ejaculation. Clin Med Insights Reprod Health. 2011;5:25–39.
   PubMedGoogle Scholar